WILMINGTON, N.C. — Christine Dingivan, a former executive at biologics firm MedImmune, is the new chief medical officer at Pharmaceutical Product Development (Nasdaq: PPDI).
Dingivan succeeds Paul Covington, who retired June 30. Covington had served as CMO since 2002.
Dingivan, a physician, will lead PPD, a global contract research organization, in assessment of medical data and set strategic direction for global regulatory affairs, pharmacovigilance, biomarker discovery services and other areas.
A graduate of Dartmouth Medical School, she also earned a degree in bioengineering at the University of Pennsylvania.
PPD names former MedImmune exec as chief medical officer
Copyright 2008 by WRAL.com. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
-
- Inspire Pharmaceuticals launches clinical trial for glaucoma treatment
Oct. 10, 2008 - Veteran life science exec to chair PhaseBio board
Oct. 10, 2008 - FDA decision means delay in $25M payment to PPD
Oct. 10, 2008 - Charlotte Biotechnology Conference to feature N.C. Research Campus
Oct. 10, 2008 - RIP, good times – Venture giant Sequoia warns execs on how to survive coming recession
Oct. 10, 2008
- Inspire Pharmaceuticals launches clinical trial for glaucoma treatment
-
- Who needs ‘crowdsourcing'? Innovation needs experts
Oct. 10, 2008 - S.C. startup MedProcure lands $150K investment
Oct. 10, 2008 - Apple to unveil new products (notebooks?) on October 14
Oct. 9, 2008 - Georgia-based Integrated Broadband Services acquires Canadian firm
Oct. 9, 2008 - Atlanta-based Multicast names CFO who had been CEO of firm acquired by ChannelAdvisor
Oct. 9, 2008
- Who needs ‘crowdsourcing'? Innovation needs experts
More from wrallocaltechwire.com
Market Watch

